相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Biomaterial-based drug delivery systems for the controlled release of neurotrophic factors
Nima Khadem Mohtaram et al.
BIOMEDICAL MATERIALS (2013)
In vitro cell migration and invasion assays
Nina Kramer et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2013)
Small molecule inhibition of the KRAS-PDEδ interaction impairs oncogenic KRAS signalling
Gunther Zimmermann et al.
NATURE (2013)
Drug Delivery Systems with Modified Release for Systemic and Biophase Bioavailability
Sorin E. Leucuta
CURRENT CLINICAL PHARMACOLOGY (2012)
Genetic and Epigenetic Alterations in Pancreatic Carcinogenesis
Yannick Delpu et al.
CURRENT GENOMICS (2011)
Pancreatic Cancer
Manuel Hidalgo
NEW ENGLAND JOURNAL OF MEDICINE (2010)
A Gene Expression Signature Associated with K-Ras Addiction Reveals Regulators of EMT and Tumor Cell Survival
Anurag Singh et al.
CANCER CELL (2009)
Pancreatic cancer
Anirban Maitra et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2008)
Molecular biology of pancreatic cancer
Cristobal Belda-Iniesta et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2008)
Activated kras, but not hras or nras, may initiate tumors of endodermal origin via stem cell expansion
Margaret P. Quinlan et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
Sian Jones et al.
SCIENCE (2008)
Oncogene addiction: setting the stage for molecularly targeted cancer therapy
Sreenath V. Sharma et al.
GENES & DEVELOPMENT (2007)
Testing transgenic regulatory elements through live mouse imaging
Naama Klopstock et al.
FEBS LETTERS (2007)
K-ras oncogene silencing strategy reduces tumor growth and enhances gemcitabine chemotherapy efficacy for pancreatic cancer treatment
Soukaina Rejiba et al.
CANCER SCIENCE (2007)
Molecular genetics of pancreatic intraepithelial neoplasia
Georg Feldmann et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY (2007)
In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro
Chun-Chi Liang et al.
NATURE PROTOCOLS (2007)
Molecular consequences of silencing mutant K-ras in pancreatic cancer cells:: Justification for K-ras-directed therapy
JB Fleming et al.
MOLECULAR CANCER RESEARCH (2005)